Data protection Impressum

Neuroscience

SensArs, an EPFL spin-off specialized in neuromodulation technology for treating chronic pain and sensory loss, has secured a pre-seed investment from HTH and two grants worth EUR 1.1 million.

SensArs secures EUR 1.1 million to advance neuromodulation technology

17 June 2024

Dandelion Science and the Wyss Center Geneva have announced a partnership to develop a generative AI platform for non-invasive brain therapies.

Dandelion Science partners with Wyss Center to pioneer AI-based brain therapies

12 June 2024

Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug development.

Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment

9 April 2024

The breakthrough comes from the University's Autophagy Laboratory, where Prof. Patricia Boya and her team, in collaboration with the Spanish Margarita Salas Center for Biological Research (CIB-CSIC), have demonstrated the potential of specific drugs to stimulate mitophagy, thereby enhancing the ability of cells to "clean house" even as they age.

University of Fribourg discovers drug to combat age-related neuroinflammation

12 February 2024

This CHF 18 million initiative focuses on developing artificial intelligence-guided neuromodulation therapies to treat neurologic and mental health disorders.

Wyss Center launches Lighthouse Partnership with key institutions from Western Switzerland

29 January 2024

1 2 3